All Stories

  1. Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma

    Article • OncoImmunology, April 2019, Taylor & Francis

    Samuel Rabkin, howard kaufman

  2. Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade

    Article • OncoImmunology, February 2019, Taylor & Francis

    Samuel Rabkin, howard kaufman